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The objective of this study was to review the growth curves for Turner syndrome, evaluate themethodological and statistical quality,
and suggest potential growth curves for clinical practice guidelines. The search was carried out in the databases Medline and
Embase. Of 1006 references identified, 15 were included. Studies constructed curves for weight, height, weight/height, body mass
index, head circumference, height velocity, leg length, and sitting height. The sample ranged between 47 and 1,565 (total = 6,273)
girls aged 0 to 24 y, born between 1950 and 2006. The number of measures ranged from 580 to 9,011 (total = 28,915). Most studies
showed strengths such as sample size, exclusion of the use of growth hormone and androgen, and analysis of confounding variables.
However, the growth curves were restricted to height, lack of information about selection bias, limited distributional properties,
and smoothing aspects. In conclusion, we observe the need to construct an international growth reference for girls with Turner
syndrome, in order to provide support for clinical practice guidelines.
1. Introduction
Turner syndrome (TS) is a chromosome abnormality [1],
occurring in 1 in 2500 to 1 in 3000 live-born girls [2]. Short
stature is one of the most common physical features in girls
with TS and growth hormone therapy is recommended for
normalization of height [1]. According to Davenport [3], the
mean final height in TS girls is 20 cm below the mean of the
normal girls. The physiological variations during the growth
makes difficult the construction of new height references for
TS girls. TheWorld Health Organization (WHO) [4] and the
Centers for Disease Control and Prevention (CDC) [5] have
constructed growth charts for children and adolescents in the
general population, but the accuracy of these curves is ques-
tionable for monitoring the growth in TS girls. Saari et al. [6]
tested the WHO curves [4] with longitudinal data of TS girls
and demonstrated that the growth references of theWHO [4]
may have important limitations for monitoring the growth
of the children with potential morbidity. Thereby, growth
curves for TS girls have been constructed in several countries.
However, it is necessary to analyze the methodological and
statistical aspects in order to provide accurate information
for monitoring of growth in TS girls. Thus, the objectives of
this study were to systematically (1) identify existing growth
curves for TS girls (2) to evaluate the methodological and
statistical quality (3) and to suggest potential growth curves
for clinical practice guidelines.
2. Methods
2.1. Search Strategy. Search strategies were developed
together with an expert librarian of the health field. The
search was carried out from September to October 2013
in databases: Medline (1950–2013) and Embase (1988–
2013). The terms were restricted in English and consulted
according to the Medical Subject Headings (MeSH): Turner
syndrome, growth chart, growth curve, growth, pattern,
standard, reference, value, weight, length, height, velocity,
head circumference, body mass index, and BMI, with the
possible suffixes. The references of the selected papers were
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Figure 1: Flowchart of the study selection process.
also reviewed. The studies were identified by the electronic
search by two independent reviewers. The date of the last
search was October 15, 2013.
2.2. Study Selection. The search process was developed
according to the PRISMA (Preferred Reporting Items for Sys-
tematic reviews and Meta-Analyses) method [7]. Two inde-
pendent reviewers evaluated the potentially relevant studies.
Inclusion criteria were (1) original papers, and (2) construc-
tion of curves for weight, length/height, growth velocity, head
circumference, and BMI. Papers were not excluded by the
use of hormonal therapy, sample size, other methodological
limitations, and inappropriate statistical analysis.
2.3. Data Extraction. The data were extracted according to
the international guidelines for the development of growth
curves [4]. Discrepancies between reviewers were discussed
and resolved by consensus meeting. Data extracted: size
sample; number of observations; size sample by karyotype
(%); age; type of study; hormone therapy (type, occurrence,
and age); spontaneous puberty (percentage, frequency, and
age); occurrence of menarche (percentage, frequency, and
age); birth year period; growth variable; country; statistical
method (mean, standard deviation, percentiles, z-scores,
smoothing aspects); exclusion criteria; and outcomes.
2.4. Data Analysis. Papers that did not provided the total
number of observations (𝑛2) were subjected to mathematical
calculations. Thus, the tables were consulted and 𝑛2 was
calculated (sum of number of observations by age). Further-
more, percentage frequency (%) was calculated to provide the
occurrence of puberty, menarche, and karyotypes.
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Table 1: Characteristics of the studies on growth curves.
Study Age(years)
Type
(study)
HT
(years)
SP %e
(years)
SM %e
(years) Birth
f L/H W HC W/H BMI HV Country
Lyon et al.
1985 [8] 1–20+ Mixed
Included
>15 h
8
(13–17) h Yes No No No No No g
Massa et al.
1990 [9] 0–22 Mixed
Included
11.3–18
17
(11.1–15)
10
(13.7–15.2) h Yes No No No No Yes Belgium
Naeraa and
Nielsen
1990 [10]
7–20a h Included13.2–24.6 h
9
(13–15) 1955–66 Yes No No No No Yes Denmark
Suwa
1992 [11] 0–20 Mixed Excluded h
3.3
(11–14) 1955–89 Yes No No No No Yes Japan
Haeusler et
al.
1992 [12]
0–16 Mixed Excluded 18.4(no/age) h 1961–81 Yes No No No No Yes Austria
Bernasconi et
al.
1994 [13]
0–21 Mixed Included(>13)
1.4
(20.8)
4.4
(20.2) 1950–90 Yes No No No No No Italy
Garcia Rudaz
et al.
1995 [14]
0–22 Mixed Included14 ± 1.2
12.7
(9–14)
h
(11–16.1) h Yes No No No No Yes Argentina
Sempe et al.
1996 [15] 0–20
b h Included h h h Yes No No No No Yes France
Rongen-
Westerlaken
et al.
1997 [16]
0–20 h Included12.8–20.1d Excluded h h Yes Yes No Yes Yes Yes
Netherlands
Denmark
Sweden
Even et al.
2000 [17] 0–3 Long h h h h Yes No No No No Yes Israel
Davenport et
al.
2002 [18]
0–8 Long Excluded Excluded h h Yes No No No No Yes USA
Roma´n et al.
2002 [19] 0–18+ h Excluded
10
(no/age) h >1968 Yes No No No No No Chile
Isojima
et al. 2009
[20]
0–20 Cross Excluded Excluded h 1970–02 Yes No No No No No Japan
Isojima
et al. 2010 [21] 0–20 Cross Excluded Excluded h 1970–06 Yes Yes No Yes Yes Yes Japan
El-Bassyouni
et al.
2012 [22]
6–24c h Excluded h h h Yes Yes Yes No Yes No Egypt
HT: hormone therapy; SP: spontaneous puberty; SM: spontaneous menarche; L/H: length/height; W: weight; HC: head circumference; W/H: weight/height;
BMI: body mass index; HV: height velocity; aHeight curve (7.5–17.5 years). bReference curves (1–21 years); c6 months to 24 years; dAge (10 and 90 percentile);
ePercentage frequency; fBirth year period; gData derived from studies (Germany—Pelz et al. [23]; Germany—Ranke et al. [24]; Finland—Lenko et al. [25];
France—Rosenberg and Tell [26]); hData not available.
3. Results
3.1. Study Selection. The search in the electronic databases
identified 1,006 studies. The exclusion of papers occurred in
three phases: (a) duplicates (𝑛 = 141); (b) papers that did
not evaluate growth charts (𝑛 = 777); (c) papers on growth
pattern, body proportion, and bone development (𝑛 = 73).
The references of the selected papers were not used (𝑛 = 0).
After the eligibility, 15 papers were included in this review [8–
22]. The search results are presented in Figure 1.
3.2. Characteristics of Studies
3.2.1. Participants. The sample size ranged between 47 and
1,565 TS girls (total = 6,273) aged 0 to 24 y, born between
1950 and 2006. Hormone therapy treatment (estrogen and
growth hormone) was observed in girls aged 11.3 to 24.6 y,
spontaneous menarche occurrence (aged 11 to 22 y), and
spontaneous puberty occurrence (variation: 1.4 to 18.4% of
sample)—Table 1. The karyotype 45,X was reported in most
studies (Table 2).
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Table 2: Size sample and karyotypes of the studies.
Study 𝑛a 𝑛b
Karyotype (%)
45,X 45,X/46,XX
46,X,
i(Xq)
45,X/46,X,
i(Xq) Others
Lyon et al.
1985 [8] 366 1517 61.8
e 16.9e 4.1e 4.6e 12.6e
Massa et al.
1990 [9] 100 637 47 7 5 13 28
Naeraa and
Nielsen
1990 [10]
78 1174 63 3 c 8 26
Suwa
1992 [11] 704 6255 36.1 c 9.8 0 54.1
Haeusler et
al.
1992 [12]
141 580 67.3 7 2.8 9.2 13.7
Bernasconi et
al.
1994 [13]
772 c 56.3 9.8 7.3 10.9 15.7
Garcia Rudaz
et al.
1995 [14]
254 2308 47 15 7 11 20
Sempe et al.
1996 [15] 167 708 58.1 31.7 c c 10.2
Rongen-
Westerlaken
et al. 1997 [16]
598 9011 c c c c c
Even et al.
2000 [17] 47 c 48.9 c 23.4 c 27.7
Davenport et
al.
2002 [18]
112 1146 57.1 12.5 4.5 c 25.9
Roma´n et al.
2002 [19] 83 668 60 25 2 9 4
Isojima et al.
2009 [20] 1447 1447
d 29.9 6 8.8 21.4 33.9
Isojima et al.
2010 [21] 1565 5772 29.6 6.1 8.8 21 34.5
El-Bassyouni
et al.
2012 [22]
93 c 59.1 40.9 c c c
Total 6273 28915
𝑛
a: number of subjects; 𝑛b: number of observations.
cData not available.
dMentioned in Isojima et al. 2010 [21].
eData derived from studies (Pelz et al. [23]; Ranke et al. [24]; Lenko et al. [25]; Rosenberg and Tell [26]).
3.2.2. Growth Curves. The curves were generated for: weight-
for-age; height-for-age; weight-for-height; BMI-for-age; head
circumference-for-age; height velocity (cm/year/age)
(Table 1). In addition, leg length-for-age and sitting height-
for-age [15] also were constructed, but not analyzed in this
study. The studies used longitudinal and cross-sectional
samples analyzing data collected from 1960 to 2008 (Table 1).
The number of anthropometric measurements ranged
between 580 and 9,011 (total = 28,915).
3.2.3. Exclusion Criteria. The exclusion criteria applied by
the studies were hormone therapy (growth hormone and/or
androgen [8, 11, 12, 14, 16, 18–22]; estrogen [12, 18, 19]);
diseases (diabetes [10, 11], hypothyroidism [10, 11], hyperthy-
roidism [11], polyarthritis [10], heart problems [11, 14, 18], and
kidney problems [11, 14]); specific karyotypes including the
Y chromosome [11, 19]; concomitant autosomal chromosome
abnormalities [18]; records that did not include at least two
successive annual measurements [15]; spontaneous puberty
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[16, 18, 20, 21]; gestational age (<37 weeks) [18]; age over 20
years [20]; lack of records about puberty [20]; highly unlikely
measurements [20]; and outliers [21].
3.2.4. Types of Curves Generated. The growth curves were
constructed using the mean, standard deviation, percentiles,
z-scores, and smoothing techniques. Seven studies [8–10, 14,
16, 19, 20] provided the number of observations with the
respective means and standard deviations by age (Table 3).
Suwa [11] showed the means and standard deviations of
height at each month in girls aged 0 to 20 y without and
with genital bleeding. The age intervals up to the two years
were as follows: (a) every one year [8, 9, 11–15, 19, 21, 22];
(b) every 6 months [20]; (c) every 3 months [16–18]. The
growth was analyzed according to karyotypes [9–13, 15, 17–
21], parents’ height [9, 10, 13], hormone therapy [8, 10, 14,
15], spontaneous puberty [9, 12–14, 19], and spontaneous
menarche [8, 10, 11, 13, 14]. Percentiles curves were generated
for weight-for-age, height-for-age, leg length-for-age, sitting
height-for-age, and height velocity [8, 12–15, 18, 20]. The
percentiles were generated for the following lines: 3rd, 10th,
25th, 50th, 75th, 90th, and 97th [14, 15, 20]. Other studies
(𝑛 = 7) [9–11, 16, 17, 21, 22] derived the percentiles within the
values corresponding to the z-score −2 and +2. Roma´n et al.
[19] presented only the values ofmean and standard deviation
by age.
3.2.5. Smoothing Aspects. The smoothing techniques for
construction of growth curves were performed in 80% of
the studies [8, 11–18, 20–22]. Examples of these methods
included (1) 4253H-twice for smoothing the data but without
giving specific detail [13], (2) “moving mean” technique
to correct the height at each month of age [11], (3) fifth-
degree polynomial applied to smooth the mean and standard
deviation of height, in order to calculate and select the centile
[14], (4) degree polynomial to mean and standard deviation
of height, weight-for-age separately for age 0–2 years and for
2–17 years, and weight-for-height [16], (5) splines for each
individual height curve to give the individual velocity height
[17], (6) LMSmethods for BMI curves [16], weight and height
curves [20], weight, weight-for-height, and BMI curves [21].
Others studies [8, 12, 15, 18] used smoothing techniques but
did not described the exact techniques for constructing the
growth curves.
3.3. Outcomes
3.3.1. TS Girls versus Normal Girls. The growth references
were compared using standard deviation score (SDS) for girls
with TS and normal girls, [8, 14, 16–18, 22]. The growth in
TS girls was significantly lower in comparison to normal girls
(SDS: −0.15 to −2.3).
3.3.2. Hormone Therapy. Most of the studies [8, 11, 12, 14, 16,
18–22] excluded the TS girls that were treated with growth
hormone and/or androgens. However, some studies [8–10,
13–15] included the girls that were treated with estrogens, and
only three studies [8, 10, 14] analyzed the effects of treatment
on the growth of TS girls. There was a significant increase
in acceleration of growth during the first year of treatment
[8, 14], but did not find significant differences on final height
[10].
3.3.3. Karyotypes. The growth was analyzed in different
karyotypes. The growth in TS girls with karyotype 45,X was
lower in comparison to TS girls with other karyotypes [9, 12].
However, Isojima et al. [21] showed that the stature in children
with 45,X was significantly higher than in other karyotypes.
Other studies [10, 11, 13, 15, 17–20] found no significant
differences.
3.3.4. Parents’ Height. Some studies [9, 10, 13] analyzed the
relation between parental height and the height of girls with
TS. Massa et al. [9] found significant positive correlation
between the parental height and the height of girls with TS
(𝑟 = 0.39). In the study of Naeraa and Nielsen [10], there
was a significant correlation between mid-parental height
and the adult height of girls with TS (𝑟 = 0.67; 𝑛 = 65).
Bernasconi et al. [13] demonstrated tendency towards higher
girls size which can be attributable to the higher heightmeans
of mothers and fathers (TS: 146.3 ± 3.4 cm, mid-parental:
169.5±3.4 cm versus TS: 139.9±6.5 cm,mid-parental: 159.4±
3.7 cm).
3.3.5. Spontaneous Puberty and Menarche. Some studies
analyzed the effects of spontaneous puberty [9, 13, 14, 19]
and menarche occurrence [8, 11, 13, 14] on the final height in
girls with TS, but found no significant differences with the
induced puberty by hormone replacement, and the absence
of menarche. In the study of Massa et al. [9], the TS girls aged
11 to 13 y with spontaneous puberty presented higher height
and height velocity in comparison to TS girls with induced
puberty.
3.3.6. Study Limitation. With regard to the reported limita-
tions, only two studies [20, 21] described the methodological
limitations for the construction of growth curves in TS girls.
They reported the limitations with regard to selection bias,
retrospective data, sample size in specific ages, cross-sectional
design, and occurrence of puberty.
4. Discussion
Growth curves are an important tool to evaluate child health
[4, 27, 28]. In 2006, the WHO constructed new curves to
follow child growth among diverse ethnic groups, socioe-
conomic conditions, and feeding mode [29]. However, the
growth patterns of children with various diseases were not
considered in international references.
Growth curves for TS girls were constructed in different
countries. In this review, we describe the main methodolog-
ical and statistical implications in each study. The curves
have important strengths and weaknesses for application in
the clinical practice. Some studies analyzed the effects of
some confounder variable on the growth in girls with TS
such as hormone therapy, spontaneous puberty, karyotypes,
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and mid-parental height. However, the relationship among
the confounder variable and the acceleration or delays of
growth appears to vary little in these studies. Length/height
curves were found in all studies as well as height velocity
in some studies. However, most did not generate curves for
weight-for-age, head circumference-for-age, weight/height-
for-age, andBMI-for-age. Although theTS girls have different
genetic and phenotypic variations, the curves forweight, head
circumference, and BMI should be more explored such as
the curves of El-Bassyouni et al. [22], Isojima et al. [21], and
Rongen-Westerlaken et al. [16].
The stature has increased in the last decades in general
population. Isojima et al. [21] demonstrated that the adult
height in TS girls followed in the studies of Suwa et al.
[11], Isojima et al. [20], and Isojima et al. [21] was 138.2 cm,
141.2 cm, and 141.3 cm, respectively. Most studies followed the
TS girls from 1950 to 1990, but did not analyze the growth
in different time periods, and more than 50% of studies did
not report the birth year period. Thus, we recommend the
analysis of secular trend for construction of new growth
curves for TS girls.
A strength observed in most studies was the number
of observations for construction of curves. Considering the
incidence of 1 : 2,500–3,000 girls born alive, the sample size
appears to be representative, although the sample calculation
is not indicated in the studies. The age interval was not
thoroughly analyzed, and few studies used age interval every
3months. It is difficult to precise the fitting of the curves from
birth to 2 years of age. Another strength of the studies is that
the girls treated with growth hormones or androgens were
excluded of the samples.However, due to the use of retrospec-
tive data, theremay be several cases omitted because of lack of
information in the medical records. In addition, the selection
bias may suggest a data bias in some situations, according
to limitation reported by Isojima et al. [20]. With regard to
environmental factors, no studies evaluated breastfeeding,
lactation support, feeding mode, socioeconomic condition,
maternal health, pediatric care, among others. de Onis et al.
[30], demonstrated that the control of the environmental
factors was necessary for construction of new curves as well
as the selection of appropriate statistical methods for sample
selection, data collection, and analysis.
A bias that is difficult to analyze is the karyotype, because
often the information is not given. Over the decades, the
techniques of realization of karyotype have improved and the
results were significantlymodified, decreasing the percentage
of 45,X cases and increasing mosaicisms and structural
aberrations of the sexual chromosomes [31].
For the construction of the curves, several statistical
methods were used such as mean, standard deviation, per-
centile, z-score, and smoothing techniques.The first strength
was the number of observations with means and standard
deviations provided by most studies, thus allowing a greater
accuracy when carrying out the comparisons between the
various studies. The main statistical limitation observed in
studies was the absence of important statistical methods
for the construction of curves such as distribution and
smoothing aspects. On the other hand, most studies used
percentiles or z-score corresponding to −2 and +2. The
distribution aspects of the anthropometric data should be
analyzed as well as the estimation of percentiles related to age
[32]. With regard to smoothing of curves, few studies have
applied the LMSmethod to evaluate asymmetry, median, and
data variability of Cole andGreen [33].The lack of smoothing
techniques can lead to the construction of irregular curves,
regardless of the use of large samples [32]. Moreover, Cole
[34] shows that mean and SD for normal data are commonly
used for the construction of curves as well as the LMSmethod
for the treatment of asymmetry. According to the WHO [4],
30 statistical methods were reviewed for the construction of
the 2006 growth curves. This involved the Box-Cox-power-
exponential (BCPE), with curve smoothing by cubic splines.
This demonstrates that the appropriate choice of statistical
methods should be performed to construct growth curves.
Thus, we suggested the examination of existing methods
that will allow identifying the best statistical technique for
construction of the growth curves in TS girls.
The strengths and limitations of growth curves should be
carefully analyzed for clinical application in girls with TS.The
main limitation for global use is their origination in a specific
country. However, for countries that lack their own growth
curve, we believe that the curves of Rongen-Westerlaken et al.
[16] appear to be more suitable for clinical applications in
children up to 2 years old mainly because the authors used
age intervals every 3 months, generated curves for height,
weight, BMI, and height velocity, and used high sample size.
Moreover, for children above 2 years, we recommend the
curves of Isojima et al. [21] for growth monitoring because
the authors used high sample sizes and age intervals every 6
month up 20 years old. In addition, they considered secular
trend, selection bias, and appropriate statistics.
5. Conclusion
In the studies on growth curves in girls with TS, we observe
the need to construct new curves for different ethnics group.
For this, an important step in the construction of the new
curves would be to analyze carefully the methodological
and statistical aspects. Furthermore, for global use, we rec-
ommend a joint effort to produce a growth curve in TS
girls for universal applicability. Finally, the findings of this
review provide support for clinical practice guidelines for the
monitoring of growth in girls with TS.
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